Performance of an automated insulin‐glucagon delivery system versus automated insulin delivery system during challenging inpatient conditions. A single‐blind randomised controlled crossover trial

Documenti analoghi

• Faster‐acting insulin aspart versus insulin aspart for adults with type 1 diabetes treated with non‐automated insulin pump and continuous glucose monitoring—A double‐blind randomized controlled crossover trial
  di: Ajenthen G. Ranjan, et al.
  Pubblicazione: (2025)
• Is low‐dose glucagon needed and effective in preventing fasted exercise‐induced hypoglycaemia in type 1 diabetes treated with the MiniMed 780G , an automated insulin delivery system?
  di: Sissel Banner Lundemose, et al.
  Pubblicazione: (2024)
• Post‐exercise glycaemic control for 24 h: Fasted morning exercise with and without glucagon in adults with type 1 diabetes using automated insulin delivery
  di: Clara Solà, et al.
  Pubblicazione: (2025)
• Postoperative insulin requirements in surgical patients receiving fully automated insulin delivery in the hospital
  di: Gabija Krutkyte, et al.
  Pubblicazione: (2025)
• Fully automated insulin delivery systems in type 1 diabetes: A systematic review and meta‐analysis
  di: Wenqi Fan, et al.
  Pubblicazione: (2025)